PI4KA and PIKfyve: Essential phosphoinositide signaling enzymes involved in myriad human diseases

Curr Opin Cell Biol. 2023 Aug:83:102207. doi: 10.1016/j.ceb.2023.102207. Epub 2023 Jul 14.

Abstract

Lipid phosphoinositides are master regulators of multiple cellular functions. Misregulation of the activity of the lipid kinases that generate phosphoinositides is causative of human diseases, including cancer, neurodegeneration, developmental disorders, immunodeficiencies, and inflammatory disease. This review will present a summary of recent discoveries on the roles of two phosphoinositide kinases (PI4KA and PIKfyve), which have emerged as targets for therapeutic intervention. Phosphatidylinositol 4-kinase alpha (PI4KA) generates PI4P at the plasma membrane and PIKfyve generates PI(3,5)P2 at endo-lysosomal membranes. Both of these enzymes exist as multi-protein mega complexes that are under myriad levels of regulation. Human disease can be caused by either loss or gain-of-function of these complexes, so understanding how they are regulated will be essential in the design of therapeutics. We will summarize insight into how these enzymes are regulated by their protein-binding partners, with a major focus on the unanswered questions of how their activity is controlled.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cell Membrane / metabolism
  • Humans
  • Lysosomes / metabolism
  • Phosphatidylinositol 3-Kinases* / metabolism
  • Phosphatidylinositols* / metabolism
  • Signal Transduction

Substances

  • Phosphatidylinositol 3-Kinases
  • Phosphatidylinositols
  • phosphatidylinositol phosphate 4-kinase
  • PIKFYVE protein, human